Ambee Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	40.4	32.64	32.74	28.57	16.92	15.09
Short-Term Investments	63.06	100	-	-	-	-
Cash & Short-Term Investments	103.46	132.64	32.74	28.57	16.92	15.09
Cash Growth	-17.99%	305.12%	14.61%	68.81%	12.12%	35.79%
Receivables	212.72	194.84	180.65	135.94	112.51	92.23
Inventory	251.13	210.8	221.91	197.25	178.89	128.89
Prepaid Expenses	0.03	0.03	0.03	0.03	0.03	0.03
Other Current Assets	39.48	39.27	69.52	64.65	100.76	85.62
Total Current Assets	606.81	577.57	504.84	426.44	409.11	321.85
Property, Plant & Equipment	98.81	103.38	85.1	87.61	95.04	99.56
Long-Term Investments	52.6	52.6	-	-	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	758.23	733.56	589.94	514.05	504.15	421.42
Accounts Payable	5.87	6.13	5.59	4.98	6.55	7.22
Accrued Expenses	33.1	31.72	20.23	19.65	53.02	79.04
Short-Term Debt	660.16	638.5	-	392.35	343.8	235.67
Current Portion of Leases	0.05	0.24	0.6	0.13	1.07	2.75
Current Income Taxes Payable	19.57	18.41	25.16	31.54	36.34	38.44
Current Unearned Revenue	-	-	4.62	-	-	-
Other Current Liabilities	1.35	2.18	499.56	35.93	3.49	5
Total Current Liabilities	720.1	697.17	555.76	484.59	444.27	368.12
Long-Term Leases	0.12	0.2	0.24	-	0.01	1.42
Long-Term Deferred Tax Liabilities	3.62	3.85	4.51	6.12	7.17	7.04
Other Long-Term Liabilities	-0	-	-	0	-	-
Total Liabilities	723.83	701.22	560.52	490.71	451.45	376.58
Common Stock	24	24	24	24	24	24
Retained Earnings	10.4	8.33	5.42	-0.66	28.7	20.84
Shareholders' Equity	34.4	32.33	29.42	23.34	52.7	44.84
Total Liabilities & Equity	758.23	733.56	589.94	514.05	504.15	421.42
Total Debt	660.32	638.94	0.84	392.48	344.88	239.85
Net Cash (Debt)	-556.86	-506.3	31.9	-363.91	-327.96	-224.75
Net Cash Per Share	-232.02	-210.96	13.29	-151.63	-136.65	-93.65
Filing Date Shares Outstanding	2.4	2.4	2.4	2.4	2.4	2.4
Total Common Shares Outstanding	2.4	2.4	2.4	2.4	2.4	2.4
Working Capital	-113.29	-119.6	-50.92	-58.15	-35.17	-46.26
Book Value Per Share	14.33	13.47	12.26	9.73	21.96	18.68
Tangible Book Value	34.4	32.33	29.42	23.34	52.7	44.84
Tangible Book Value Per Share	14.33	13.47	12.26	9.73	21.96	18.68
Land	50.25	50.25	50.25	50.25	50.25	50.25
Buildings	29.95	29.95	29.95	29.95	29.95	29.08
Machinery	174.25	174.25	150.46	148.26	148.15	147.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.